This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Marjorie Romkes: Innovator in Cancer Treatment
Introduction
Marjorie Romkes is a prominent inventor based in San Diego, CA, known for her significant contributions to cancer treatment methodologies. With a focus on genomic variants, her work aims to enhance the effectiveness of chemotherapy through innovative approaches.
Latest Patents
Romkes holds a patent titled "PARP genomic variants conferring resistance and sensitization to chemotherapy under inhibition." This patent outlines a method for selecting cancer patients as candidates for treatment with a PARP1 inhibitor, or a combination of a PARP1 inhibitor and a chemotherapeutic agent. The method involves detecting mutations in a non-coding region of the PARP1 gene, which can indicate the suitability of treatment with the PARP1 inhibitor, such as verliparib (ABT-888).
Career Highlights
Romkes has made significant strides in her career, particularly through her work at the University of Pittsburgh. Her research focuses on the intersection of genetics and cancer therapy, contributing to advancements in personalized medicine.
Collaborations
Some of her notable coworkers include Hussein A Tawbi and Petr Pancoska, who have collaborated with her on various research projects aimed at improving cancer treatment outcomes.
Conclusion
Marjorie Romkes is a trailblazer in the field of cancer research, with her innovative patent paving the way for more effective treatment options. Her work exemplifies the critical role of inventors in advancing medical science and improving patient care.